MagicMed Industries CEO Dr. Joseph Tucker joined Steve Darling from Proactive with news the company completed the development of their psilocybin-derivatives patent portfolio which they call “The Psybrary”
Tucker says the Psybrary is a collection of novel psychedelic-derivative drug candidates, manufacturing methods, and pharmacological.
Tucker also told Proactive thew company has filed 12 patent applications directed to 9 different chemical compound categories covering over 125 million individual molecules.
Add related topics to MyProactive
Create your account: sign up and get ahead on news and events
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of MagicMed Industries Inc named herein, including the promotion by the Company of MagicMed Industries Inc in any Content on the Site, the Company...
FOR OUR FULL DISCLAIMER CLICK HERE
